If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for April 16 2013
DrugPatentWatch Serves Your Competitive Intelligence
Needs
Subscribers have
access to valuable datasets, including:
- Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information
- Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export
- More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for April 14 2013
DrugPatentWatch Serves Your Competitive Intelligence
Needs
Subscribers have
access to valuable datasets, including:
- Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information
- Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export
- More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
As I continue to investigate global biotechnology for Scientific American and international patenting trends for DrugPatentWatch.com, I came across a curious finding. I was looking at the global spread of US drug patents — to obtain global patent protection for drugs companies must file for patents in each of the jurisdictions that they seek protection, within […]
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for April 3 2013
DrugPatentWatch Serves Your Competitive Intelligence
Needs
Subscribers have
access to valuable datasets, including:
- Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information
- Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export
- More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
This live infographic dynamically shows the number of pending patent expirations by year for the next ten years. For more infographics, see the DrugPatentWatch Pharmaceutical Innovation Infographics. Do you have a response to this infographic? Respond in the comments section below.
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
I continue to measure global biotechnology innovation in the fifth edition of Scientific American Worldview. This special publication is the foundation I use for my talks on global biotechnology (see my recent talk on Building Biotechnology in India). I will be serving on a panel on April 24th at 2pm, and Fareed Zakaria will be moderating […]
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
This infographic from DrugPatentWatch shows that Sanofi Aventis Us, Merck, Glaxosmithkline, Abbvie, Abraxis Bioscience, Genzyme, Abbott Endocrine,Boehringer Ingelheim, Merck And Co Inc, and Vyteris face the most patent expirations this year. Perhaps not surprisingly, GlaxoSmithKline and Sanofi Aventis are also among the firms with the most drug patents. For more infographics, see the DrugPatentWatch Pharmaceutical Innovation Infographics. Do you have a response to this infographic? […]
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
Join Michael Salgaller and I as we will be signing our books at the BIO bookstore on Tuesday April 23rd. Michael will be signing Biotechnology Entrepreneurship From Science to Solutions from 12:30 to 2pm. I will be signing Building Biotechnology, Best Practices in Biotechnology Business Development, the Journal of Commercial Biotechnology, and also giving demos of […]
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for March 26 2013
DrugPatentWatch Serves Your Competitive Intelligence
Needs
Subscribers have
access to valuable datasets, including:
- Patent litigation
- Clinical trial information
- International patent families
- International patent priority and PCT
information
- Patent maintenance
- Full-text patent downloads
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Dynamic search capabilities with data
export
- More…
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. A common first reaction to crowdfunding for life sciences may be to dismiss it out of hand. Given the undeniable chill in early stage funding, it is worth giving the […]
Click here for reuse options!
Copyright 2013 Biotechblog
Like this:
Like Loading...
